{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:31:11Z","timestamp":1761129071015},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T00:00:00Z","timestamp":1363392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s10067-013-2233-3","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T04:12:03Z","timestamp":1363407123000},"page":"1029-1036","source":"Crossref","is-referenced-by-count":17,"title":["Spironolactone improves endothelial dysfunction in ankylosing spondylitis"],"prefix":"10.1007","volume":"32","author":[{"given":"Ashit","family":"Syngle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanchan","family":"Vohra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh","family":"Khichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inderjeet","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladbans","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,16]]},"reference":[{"key":"2233_CR1","first-page":"S11","volume":"20","author":"D Lautermann","year":"2002","unstructured":"Lautermann D, Braun J (2002) Ankylosing spondylitis\u2014cardiac manifestations. Clin Exp Rheumatol 20:S11\u2013S15","journal-title":"Clin Exp Rheumatol"},{"key":"2233_CR2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/ard.52.3.174","volume":"52","author":"K Lehtinen","year":"1993","unstructured":"Lehtinen K (1993) Mortality and causes of death in 398 patients admitted with ankylosing spondylitis. Ann Rheum Dis 52:174\u2013176","journal-title":"Ann Rheum Dis"},{"key":"2233_CR3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.autrev.2005.12.006","volume":"5","author":"A Abou-Raya","year":"2006","unstructured":"Abou-Raya A, Abou-Raya S (2006) Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev 5:331\u2013337","journal-title":"Autoimmun Rev"},{"key":"2233_CR4","first-page":"S124","volume":"27","author":"D McCarey","year":"2009","unstructured":"McCarey D, Sturrock RD (2009) Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis. Clin Exp Rheumatol 27:S124\u2013S126","journal-title":"Clin Exp Rheumatol"},{"key":"2233_CR5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10067-010-1402-x","volume":"29","author":"A Syngle","year":"2010","unstructured":"Syngle A, Vohra K, Sharma A, Kaur L (2010) Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-\u03b1 blockade. Clin Rheumatol 29:763\u2013770","journal-title":"Clin Rheumatol"},{"key":"2233_CR6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/ard.2007.086777","volume":"66","author":"IC Ejick Van","year":"2009","unstructured":"Van Ejick IC, Peters MJL, Seme EH, van der Horst-bruinsma IE, Dijkmans BAC, Smulders YM, Nurmohamed MT (2009) Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor \u03b1 blockade. Ann Rheum Dis 66:362\u2013366","journal-title":"Ann Rheum Dis"},{"key":"2233_CR7","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00296-006-0147-y","volume":"26","author":"W Bilsborough","year":"2006","unstructured":"Bilsborough W, Keen H, Taylor A, O\u2019Driscoll GJ, Arnolda L, Green DJ (2006) Anti tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis. Rheumatol Int 26:1125\u20131131","journal-title":"Rheumatol Int"},{"key":"2233_CR8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2249.2003.02249.x","volume":"134","author":"K Bendtzen","year":"2003","unstructured":"Bendtzen K, Hansen PR, Rieneck K (2003) Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-\u03b1 and interferon-\u03b3, and has potential in the treatment of arthritis. Clin Exp Immunol 134:151\u2013158","journal-title":"Clin Exp Immunol"},{"key":"2233_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/03009740802279709","volume":"38","author":"A Syngle","year":"2009","unstructured":"Syngle A, Vohra K, Kaur L, Sharma S (2009) Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis. Scand J Rheumatol 38:15\u201322","journal-title":"Scand J Rheumatol"},{"key":"2233_CR10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/hrt.2003.017368","volume":"90","author":"JE Mac Donald","year":"2004","unstructured":"Mac Donald JE (2004) Effect of spironolactone on endothelial function, vascular angiotensin converting enzyme activity and other prognostic marker in patients with mild heart failure already taking optimal treatment. Heart 90:765\u2013770","journal-title":"Heart"},{"key":"2233_CR11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"LS Vander","year":"1984","unstructured":"Vander LS, Valkerburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368","journal-title":"Arthritis Rheum"},{"key":"2233_CR12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.berh.2007.02.010","volume":"21","author":"J Zochling","year":"2007","unstructured":"Zochling J, Braun J, van der Heijde D (2007) Assessments in ankylosing spondylitis. Best Pract Res Clin Rheumatol 21:699\u2013712","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2233_CR13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/abio.2002.5676","volume":"306","author":"KV Sastry","year":"2002","unstructured":"Sastry KV, Moudgal RP, Mohan J, Tyagi JS, Rao GS (2002) Spectrophotometric determination of serum nitrite and nitrate by copper\u2013cadmium alloy. Anal Biochem 306:79\u201382","journal-title":"Anal Biochem"},{"key":"2233_CR14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1006\/niox.1999.0261","volume":"3","author":"A Wanchu","year":"1999","unstructured":"Wanchu A, Khullar M, Sud A, Bambrey P (1999) Nitric oxide production is increased in patients with inflammatory myositis. Nitric oxide 3:454\u2013458","journal-title":"Nitric oxide"},{"key":"2233_CR15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1620\/tjem.199.95","volume":"199","author":"M Himento","year":"2003","unstructured":"Himento M, Ishibashi T, Nakano S, Furuya K, Kigoshi T, Uchida K et al (2003) A practical procedure for achieving a steady state of NOx concentration in plasma: with special to NOx content of Japanese daily food. Tohoku J Exp Med 199:95\u2013110","journal-title":"Tohoku J Exp Med"},{"key":"2233_CR16","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","volume":"106","author":"D Hurlimann","year":"2002","unstructured":"Hurlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O et al (2002) Anti-tumour necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106:2184\u20132187","journal-title":"Circulation"},{"key":"2233_CR17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.berh.2006.03.011","volume":"20","author":"J Zochling","year":"2006","unstructured":"Zochling J, Braun J, van der Heijde D (2006) Assessments in ankylosing spondylitis. Best Pract Res Clin Rheumatol 20:521\u2013537","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2233_CR18","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1161\/01.CIR.0000148821.97162.5E","volume":"110","author":"JA Vita","year":"2004","unstructured":"Vita JA, Keaney JF, Larson MG, Keyes MJ, Massaro JM, Lipinska I et al (2004) Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation 110:3604\u20133609","journal-title":"Circulation"},{"key":"2233_CR19","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/01.ATV.0000033516.73864.4E","volume":"22","author":"R Bergholm","year":"2002","unstructured":"Bergholm R, Leirisalo-Repo M, Vehkavaara S, M\u00e4kimattila S, Taskinen MR, Yki-J\u00e4rvinen H (2002) Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Arterioscler Thromb Vasc Biol 22:1637\u20131641","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2233_CR20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10067-010-1589-x","volume":"30","author":"GL Erre","year":"2011","unstructured":"Erre GL, Sanna P, Zinellu A, Ponchietti A, Fenu P, Sotgia S, Carru C et al (2011) Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study. Clin Rheumatol 30:21\u201327","journal-title":"Clin Rheumatol"},{"key":"2233_CR21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/rheumatology\/kei145","volume":"45","author":"I Sari","year":"2006","unstructured":"Sari I, Okan T, Akar S, Cece H, Ataly C, Secil M et al (2006) Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology 45:283\u2013286","journal-title":"Rheumatology"},{"key":"2233_CR22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/ard.61.1.76","volume":"61","author":"Y Ersoy","year":"2002","unstructured":"Ersoy Y, Ozerol E, Baysal O, Temel I, MacWalter RS, Meral U, Altay ZE (2002) Serum nitrate and nitrite levels in patients with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. Ann Rheum Dis 61:76\u201378","journal-title":"Ann Rheum Dis"},{"key":"2233_CR23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/ard.51.11.1219","volume":"51","author":"AJ Farrell","year":"1992","unstructured":"Farrell AJ, Blake DR, Palmer RM, Moncada S (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51:1219\u20131222","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2233_CR24","doi-asserted-by":"crossref","first-page":"H1016","DOI":"10.1152\/ajpheart.00779.2004","volume":"288","author":"E Vila","year":"2005","unstructured":"Vila E, Salaices M (2005) Cytokines and vascular reactivity in resistance arteries. Am J Physiol Heart Circ Physiol 288(3):H1016\u2013H1021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2233_CR25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/rheumatology\/36.8.831","volume":"36","author":"SH Ralston","year":"1997","unstructured":"Ralston SH (1997) Nitric oxide and bone: what a gas! Br J Rheumatol 36:831\u2013838","journal-title":"Br J Rheumatol"},{"key":"2233_CR26","first-page":"375","volume":"82","author":"MT Betero","year":"1997","unstructured":"Betero MT, Caligaris-Cappio F (1997) Anemia of chronic disorders in systemic autoimmune disease. Haematologica 82:375\u2013381","journal-title":"Haematologica"},{"key":"2233_CR27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1756-185X.2011.01679.x","volume":"15","author":"A Syngle","year":"2012","unstructured":"Syngle A, Vohra K, Garg N, Kaur L, Chand P (2012) Advanced glycation end products inhibition improves endothelial dysfunction in rheumatoid arthritis. Int J Rheum Dis 15:45\u201355","journal-title":"Int J Rheum Dis"},{"key":"2233_CR28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0021-9150(02)00380-5","volume":"167","author":"M Saito","year":"2003","unstructured":"Saito M, Ishimitsu T, Minami J, Ono H, Ohrui M, Matsuoka H (2003) Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 167:73\u201379","journal-title":"Atherosclerosis"},{"key":"2233_CR29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.HYP.0000130484.20501.df","volume":"44","author":"I Jialal","year":"2004","unstructured":"Jialal I, Devaraj S, Venugopal SK (2004) C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 44:6\u201311","journal-title":"Hypertension"},{"key":"2233_CR30","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/01.CIR.0000033116.22237.F9","volume":"106","author":"SK Venugopal","year":"2002","unstructured":"Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I (2002) Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 106:1439\u20131441","journal-title":"Circulation"},{"key":"2233_CR31","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/01.CIR.103.21.2531","volume":"103","author":"V Pasceri","year":"2001","unstructured":"Pasceri V, Cheng JS, Willerson JT, Yeh ET (2001) Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103:2531\u20132534","journal-title":"Circulation"},{"key":"2233_CR32","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","volume":"102","author":"F Zannad","year":"2000","unstructured":"Zannad F, Alla F, Dousset B, Perez A, Pitt B (2000) Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the Randomized Aldactone Evaluation Study (RALES). Circulation 102:2700\u20132706","journal-title":"Circulation"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2233-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-013-2233-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2233-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:25Z","timestamp":1559120245000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-013-2233-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,16]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["2233"],"URL":"https:\/\/doi.org\/10.1007\/s10067-013-2233-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,16]]}}}